← Back to Patent Explorer
US4591599A Expired / Lapsed US ⏱️ 0.0 years remaining

Perfluoropyrrolizines and emulsions thereof useful as blood substitutes

Assignee: Tanabe Pharma Corp
•
Filing: 1984-11-13
•
Granted: 1986-05-27
•
Expires: 2004-11-13
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A perfluorobicyclo compound of the general formula: <IMAGE> wherein either or both of Ring A and Ring B may optionally be substituted with lower perfluoroalkyl group (s) and m and n each represent 3 or 4.

Inventors

  • 👤 Kazumasa Yokoyama
  • 👤 Chikara Fukaya
  • 👤 Yoshio Tsuda
  • 👤 Taizo Ono
  • 👤 Yoshio Arakawa
  • 👤 Tadakazu Suyama

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:29
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0026; C; C07; C07D; C07D455/00; C07D455/02; C07D471/00; C07D471/02; C07D471/04; C07D487/00; C07D487/02; C07D487/04; C25; C25B; C25B3/00; C25B3/01; C25B3/05; C25B3/09; C25B3/11; C25B3/20; C25B3/27; C25B3/28

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 48 words
A perfluoropyrrolizine compound of the formula: ##STR104## in which either the A ring, the B ring, or both are substituted with at least one C 1 to C 3 perfluoroalkyl group provided that the total number of carbon atoms in the perfluoropyrrolizine compound is from 8 to 12.
Claim 2
Dependent Claim 48 words
A perfluoropyrrolizine compound of the formula: ##STR104## in which either the A ring, the B ring, or both are substituted with at least one C 1 to C 3 perfluoroalkyl group provided that the total number of carbon atoms in the perfluoropyrrolizine compound is from 8 to 12.
Claim 3
Dependent Claim 19 words
The perfluoro compound of claim 1 in which the total number of carbon atoms is from 9 to 11.
Claim 4
Dependent Claim 98 words
An emulsion useful as a blood substitute containing a perfluorobicyclo compound capable of carrying oxygen, said emulsion comprising: 5-50% (w/v) of a perfluoropyrrolizine compound of the formula: ##STR105## in which the A ring, the B ring, or both are substituted with at least one C 1 to C 3 perfluoroalkyl group provided that the total number of carbon atoms in the perfluoropyrrolizine compound is from 8 to 12, as an oxygen-carrying component; - 5% (w/v) of an emulsifying agent, and a physiologically acceptable aqueous solution as the balance, the emulsion having a particle diameter of 0.3μ or less.
Claim 5
Dependent Claim 98 words
An emulsion useful as a blood substitute containing a perfluorobicyclo compound capable of carrying oxygen, said emulsion comprising: 5-50% (w/v) of a perfluoropyrrolizine compound of the formula: ##STR105## in which the A ring, the B ring, or both are substituted with at least one C 1 to C 3 perfluoroalkyl group provided that the total number of carbon atoms in the perfluoropyrrolizine compound is from 8 to 12, as an oxygen-carrying component; - 5% (w/v) of an emulsifying agent, and a physiologically acceptable aqueous solution as the balance, the emulsion having a particle diameter of 0.3μ or less.
Claim 6
Dependent Claim 18 words
The emulsion of claim 3 in which the total number of carbon atoms is from 9 to 11.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-05-26 1989-11-25 1990-05-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-05-26 1993-11-25 1994-05-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-05-26 1997-11-25 1998-05-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag